← Open Payments lookup

CHRISTOPHER VAN HORN: Open Payments

NPI 1306825229 · LEAWOOD, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,202 in 133 payments from 18 companies in 2025. Trend: 2023 $1,512 · 2024 $2,001 · 2025 $2,202

Food & beverage: $2,202
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.23$364
Vanda Pharmaceuticals Inc.13$319
ABBVIE INC.22$276
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)19$255
E.R. Squibb & Sons, L.L.C.14$181
Neurocrine BioSciences, Inc.7$143
Takeda Pharmaceuticals U.S.A., Inc.7$141
Supernus Pharmaceuticals, Inc.5$99
Lundbeck LLC4$98
Almatica Pharma LLC4$78

Products named: REXULTI, VRAYLAR, HETLIOZ, CAPLYTA, COBENFY, ABILIFY ASIMTUFII, INGREZZA, TRINTELLIX.

Industry payments across KS — which companies pay providers there.